Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Aim: This study investigated the association between serum 25-hydroxyvitamin D (25(OH)D) levels, systemic inflammation, and exacerbation frequency among patients with COPD GOLD group E.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Methods: A cross-sectional study was conducted on 111 patients with stable COPD.

Source: Abstract.

Patients were recruited consecutively between August 2012 and October 2018.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Serum Vitamin D Levels, Systemic Inflammation, and Exacerbation Among Patients with COPD GOLD Group E

Cross-sectional study · Biomedicines · 2026

Original publication title

Serum Vitamin D Levels, Systemic Inflammation, and Exacerbation Among Patients with COPD GOLD Group E

Apostolos Sioutas; Hans Lennart Persson

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

Chronic obstructive pulmonary disease (COPD) is associated with systemic inflammation and frequent exacerbations, leading to disease progression and increased morbidity. Vitamin D deficiency has been suggested to contribute to COPD inflammation and exacerbations.

Aim:

This study investigated the association between serum 25-hydroxyvitamin D (25(OH)D) levels, systemic inflammation, and exacerbation frequency among patients with COPD GOLD group E.

Methods:

A cross-sectional study was conducted on 111 patients with stable COPD. Patients were divided into two groups based on their serum 25(OH)D levels (<50 nmol/L vs. ≥50 nmol/L). Data on exacerbation frequency for the past year, inflammatory markers, spirometric lung function parameters, and symptom burden were collected.

Results:

Patients with low serum 25(OH)D (<50 nmol/L) had a significantly higher CAT score and level of serum high-sensitivity (hs)-CRP and exhibited significantly more exacerbations compared to those with higher 25(OH)D levels (p < 0.001, p < 0.001, and p < 0.0001, respectively). Furthermore, lower vitamin D levels were associated with higher CAT scores (Pearson’s correlation coefficient, r = −0.30, p < 0.01) and higher serum hs-CRP levels (Spearman’s rank correlation coefficient, r = −0.25, p < 0.01), as well as a higher number of exacerbations (Pearson’s correlation coefficient, r = −0.74, p < 0.0001).

Conclusions:

Low vitamin D levels are significantly associated with greater symptom burden, elevated hs-CRP, and increased exacerbation frequency, indicating a strong relationship between vitamin D deficiency, systemic inflammation, and disease burden in patients with COPD belonging to GOLD group E. However, due to the cross-sectional design, no causal relationship can be inferred and prospective interventional studies are required to determine whether treating vitamin D deficiency improves clinical outcomes.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study investigated the association between serum 25-hydroxyvitamin D (25(OH)D) levels, systemic inflammation, and exacerbation frequency among patients with COPD GOLD group E.

Source: Aim

Abstract: Results

Patients with low serum 25(OH)D (<50 nmol/L) had a significantly higher CAT score and level of serum high-sensitivity (hs)-CRP and exhibited significantly more exacerbations compared to those with higher 25(OH)D levels (p < 0.001, p < 0.001, and p < 0.0001, respectively). Furthermore, lower vitamin D levels were associated with higher CAT scores (Pearson’s correlation coefficient, r = −0.30, p < 0.01) and higher serum hs-CRP levels (Spearman’s rank correlation coefficient, r = −0.25, p < 0.01), as well as a higher number of exacerbations (Pearson’s correlation coefficient, r = −0.74, p < 0.0001).

Source: Results

Abstract: Conclusions

Low vitamin D levels are significantly associated with greater symptom burden, elevated hs-CRP, and increased exacerbation frequency, indicating a strong relationship between vitamin D deficiency, systemic inflammation, and disease burden in patients with COPD belonging to GOLD group E. However, due to the cross-sectional design, no causal relationship can be inferred and prospective interventional studies are required to determine whether treating vitamin D deficiency improves clinical outcomes.

Source: Conclusions
Authors’ abstract

Background:

Chronic obstructive pulmonary disease (COPD) is associated with systemic inflammation and frequent exacerbations, leading to disease progression and increased morbidity. Vitamin D deficiency has been suggested to contribute to COPD inflammation and exacerbations.

Aim:

This study investigated the association between serum 25-hydroxyvitamin D (25(OH)D) levels, systemic inflammation, and exacerbation frequency among patients with COPD GOLD group E.

Methods:

A cross-sectional study was conducted on 111 patients with stable COPD. Patients were divided into two groups based on their serum 25(OH)D levels (<50 nmol/L vs. ≥50 nmol/L). Data on exacerbation frequency for the past year, inflammatory markers, spirometric lung function parameters, and symptom burden were collected.

Results:

Patients with low serum 25(OH)D (<50 nmol/L) had a significantly higher CAT score and level of serum high-sensitivity (hs)-CRP and exhibited significantly more exacerbations compared to those with higher 25(OH)D levels (p < 0.001, p < 0.001, and p < 0.0001, respectively). Furthermore, lower vitamin D levels were associated with higher CAT scores (Pearson’s correlation coefficient, r = −0.30, p < 0.01) and higher serum hs-CRP levels (Spearman’s rank correlation coefficient, r = −0.25, p < 0.01), as well as a higher number of exacerbations (Pearson’s correlation coefficient, r = −0.74, p < 0.0001).

Conclusions:

Low vitamin D levels are significantly associated with greater symptom burden, elevated hs-CRP, and increased exacerbation frequency, indicating a strong relationship between vitamin D deficiency, systemic inflammation, and disease burden in patients with COPD belonging to GOLD group E. However, due to the cross-sectional design, no causal relationship can be inferred and prospective interventional studies are required to determine whether treating vitamin D deficiency improves clinical outcomes.

Publication and source details

Original title: Serum Vitamin D Levels, Systemic Inflammation, and Exacerbation Among Patients with COPD GOLD Group E

Apostolos Sioutas; Hans Lennart Persson

Biomedicines · 2026

* Correspondence: apostolos.sioutas@regionostergotland.se© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Medical Research Council of Southeast Sweden (FORSS)https://ror.org/00brmfv24 FORSS-994744The study was supported by the Medical Research Council of Southeast Sweden (FORSS) (grant no. FORSS-994744). The founders had no role in study design, data collection, or analysis.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:29:15.883740+00:00

DOI: 10.3390/biomedicines14040833 · PMC13113543